Commonwealth Equity Services
TEVA icon

Commonwealth Equity Services’s Teva Pharmaceuticals TEVA Stock Holding History

Commonwealth Equity Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45M Sell
131,451
-14,557
-10% -$485K 0.01% 1500
2026
Q1 		$4.4M Sell
146,008
-5,209
-3% -$168K 0.01% 1422
2025
Q4 		$4.72M Sell
151,217
-134,519
-47% -$3.31M 0.01% 1363
2025
Q3 		$5.77M Buy
285,736
+122,701
+75% +$2.16M 0.01% 1245
2025
Q2 		$2.73M Sell
163,035
-2,596
-2% -$41.9K ﹤0.01% 1756
2025
Q1 		$2.55M Buy
165,631
+7,316
+5% +$131K ﹤0.01% 1741
2024
Q4 		$3.49M Sell
158,315
-15,281
-9% -$278K 0.01% 1475
2024
Q3 		$3.13M Buy
173,596
+10,826
+7% +$189K ﹤0.01% 1552
2024
Q2 		$2.65M Sell
162,770
-107,533
-40% -$1.66M ﹤0.01% 1603
2024
Q1 		$3.81M Sell
270,303
-38,072
-12% -$480K 0.01% 1348
2023
Q4 		$3.22M Buy
308,375
+52,898
+21% +$494K 0.01% 1382
2023
Q3 		$2.61M Buy
255,477
+12,587
+5% +$117K 0.01% 1432
2023
Q2 		$1.83M Buy
242,890
+72,588
+43% +$589K ﹤0.01% 1684
2023
Q1 		$1.51M Buy
170,302
+50,006
+42% +$494K ﹤0.01% 1745
2022
Q4 		$1.1M Buy
120,296
+296
+0.2% +$2.58K ﹤0.01% 1908
2022
Q3 		$968K Sell
120,000
-7,815
-6% -$69.1K ﹤0.01% 1916
2022
Q2 		$961K Sell
127,815
-1,880
-1% -$16.4K ﹤0.01% 1930
2022
Q1 		$1.22M Sell
129,695
-14,784
-10% -$123K ﹤0.01% 1848
2021
Q4 		$1.16M Sell
144,479
-22,777
-14% -$206K ﹤0.01% 1881
2021
Q3 		$1.63M Sell
167,256
-2,205
-1% -$20.6K ﹤0.01% 1570
2021
Q2 		$1.68M Sell
169,461
-13,447
-7% -$142K ﹤0.01% 1549
2021
Q1 		$2.11M Buy
182,908
+14,317
+8% +$164K 0.01% 1282
2020
Q4 		$1.63M Buy
168,591
+9,381
+6% +$89.9K ﹤0.01% 1343
2020
Q3 		$1.43M Sell
159,210
-25,832
-14% -$273K ﹤0.01% 1282
2020
Q2 		$2.28M Sell
185,042
-2,965
-2% -$33.5K 0.01% 971
2020
Q1 		$1.69M Buy
188,007
+25,428
+16% +$261K 0.01% 974
2019
Q4 		$1.59M Sell
162,579
-6,961
-4% -$62.1K 0.01% 1160
2019
Q3 		$1.17M Buy
169,540
+9,262
+6% +$71K 0.01% 1273
2019
Q2 		$1.48M Buy
160,278
+5,068
+3% +$61.1K 0.01% 1118
2019
Q1 		$2.43M Sell
155,210
-5,714
-4% -$101K 0.01% 837
2018
Q4 		$2.48M Sell
160,924
-23,357
-13% -$479K 0.01% 752
2018
Q3 		$3.97M Buy
184,281
+25,123
+16% +$583K 0.02% 611
2018
Q2 		$3.87M Sell
159,158
-6,284
-4% -$128K 0.02% 598
2018
Q1 		$2.83M Buy
165,442
+1,175
+0.7% +$22.9K 0.02% 695
2017
Q4 		$3.11M Buy
164,267
+4,102
+3% +$61.7K 0.02% 643
2017
Q3 		$2.82M Sell
160,165
-7,732
-5% -$174K 0.02% 642
2017
Q2 		$5.58M Buy
167,897
+2,742
+2% +$84.9K 0.04% 404
2017
Q1 		$5.3M Buy
165,155
+28,816
+21% +$983K 0.04% 399
2016
Q4 		$4.94M Buy
136,339
+17,819
+15% +$711K 0.04% 385
2016
Q3 		$5.45M Sell
118,520
-20,105
-15% -$1.05M 0.04% 348
2016
Q2 		$6.96M Buy
138,625
+38,948
+39% +$2.07M 0.06% 290
2016
Q1 		$5.33M Buy
99,677
+2,033
+2% +$119K 0.05% 331
2015
Q4 		$6.41M Buy
97,644
+652
+0.7% +$40.3K 0.06% 286
2015
Q3 		$5.48M Buy
96,992
+5,803
+6% +$376K 0.06% 295
2015
Q2 		$5.39M Sell
91,189
-5,829
-6% -$360K 0.05% 311
2015
Q1 		$6.04M Sell
97,018
-838
-0.9% -$48.7K 0.06% 269
2014
Q4 		$5.63M Buy
97,856
+3,389
+4% +$189K 0.06% 266
2014
Q3 		$5.08M Buy
94,467
+1,391
+1% +$73.7K 0.06% 273
2014
Q2 		$4.88M Buy
93,076
+1,095
+1% +$56K 0.06% 286
2014
Q1 		$4.86M Sell
91,981
-33,651
-27% -$1.56M 0.07% 267
2013
Q4 		$5.04M Buy
125,632
+24,778
+25% +$976K 0.07% 255
2013
Q3 		$3.81M Buy
100,854
+11,874
+13% +$463K 0.06% 285
2013
Q2 		$3.49M Buy
+88,980
New +$3.47M 0.06% 288

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Commonwealth Equity Services's TEVA Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Teva Pharmaceuticals (TEVA) stake by 10% in Q2 2026, selling an estimated $485K and leaving 131,451 shares worth $4.45M. The position accounts for 0.01% of the portfolio, ranked #1500.

Commonwealth Equity Services first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.96M in Q2 2016. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Commonwealth Equity Services held 131,451 shares of Teva Pharmaceuticals worth $4.45M as of Q2 2026.
  • Commonwealth Equity Services sold 14,557 Teva Pharmaceuticals shares in Q2 2026, an estimated $485K.
  • Teva Pharmaceuticals made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1500 holding.
  • Commonwealth Equity Services first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Commonwealth Equity Services's Teva Pharmaceuticals position peaked at $6.96M in Q2 2016.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.